Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Colombel, J.-F.
678  Ergebnisse:
Personensuche X
?
1

OP39 Vedolizumab response in ulcerative colitis associates ..:

Canales-Herrerias, P ; Uzzan, M ; Al-taie, Z...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i69-i70 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DOP18 Efficacy of risankizumab versus ustekinumab by baseli..:

Peyrin-Biroulet, L ; Colombel, J F ; D'Haens, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i104-i105 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P664 Anti-TNF exposure is associated with an increased risk..:

Bourgonje, A R ; Posner, H ; Mehandru, S..
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1264-i1265 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P734 Super-responders in patients with moderate-to-severe C..:

Schreiber, S W ; Sands, B E ; Hanauer, S B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1375-i1376 , 2024
Link: https://doi.org/10.1093/..
 
?
5

DOP05 Bowel damage and its correlation with the disability ..:

Revés, J ; Roager Madsen, G ; Burisch, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i79-i80 , 2024
Link: https://doi.org/10.1093/..
 
?
6

DOP33 Distinct perturbances in metabolic pathways associate..:

Bourgonje, A R ; Ibing, S ; Argmann, C...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i131-i133 , 2024
Link: https://doi.org/10.1093/..
 
?
7

DOP68 Natural history of isolated Crohn's Disease perianal ..:

Sangmo, L ; Quraishi, B ; Rajauria, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i196-i198 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P253 Knowledge and acceptability of the Lémann Index to mea..:

Wong, C ; Torres, J ; Burisch, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i606-i607 , 2024
Link: https://doi.org/10.1093/..
 
?
9

P1093 Early life exposure to agriculture and biodiversity i..:

Agrawal, M ; Vinkel Hansen, A ; Colombel, J F..
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1964-i1965 , 2024
Link: https://doi.org/10.1093/..
 
?
10

P704 Safety of Immunosuppression in A Prospective Cohort of..:

Axelrad, J ; Jiang, Y ; Colombel, J F...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1329-i1329 , 2024
Link: https://doi.org/10.1093/..
 
?
11

P593 Efficacy of Risankizumab in Patients With Moderately t..:

Panaccione, R ; Louis, E ; Colombel, J F...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1153-i1155 , 2024
Link: https://doi.org/10.1093/..
 
?
12

P104 Per- and poly-fluoroalkyl substances (PFAS) exposure i..:

Agrawal, M ; Midya, V ; Picker, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i386-i387 , 2024
Link: https://doi.org/10.1093/..
 
?
13

P1008 Efficacy and safety of retreatment with upadacitinib ..:

Panaccione, R ; Colombel, J F ; Dubinsky, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1821-i1822 , 2024
Link: https://doi.org/10.1093/..
 
?
14

P226 Disability in Crohn's Disease Patients at diagnosis: F..:

Revés, J ; Roager Madsen, G ; Burisch, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i563-i564 , 2024
Link: https://doi.org/10.1093/..
 
?
15

P902 Subcutaneous infliximab (CT-P13 SC) as maintenance the..:

Colombel, J F ; Hanauer, S B ; Sandborn, W J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1653-i1654 , 2024
Link: https://doi.org/10.1093/..
 
1-15